Whitehead Moves to Block Alnylam, Max Planck Motion to Halt Tuschl-I Patent Prosecution
July 30, 2009
Whitehead Moves to Block Alnylam, Max Planck Motion to Halt Tuschl-I Patent Prosecution
According to Whitehead, Alnylam and Max Planck's request to block the case represents an "eleventh hour … rush into court to seek emergency relief from a situation of their own making," and should therefore be denied.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Alnylam, Max Planck Settle Suit Over Tuschl IP
March 17, 2011 / Gene Silencing News - For Some RNAi Rx Shops, Industry Deals with Bigger Players are Par for the Course
August 20, 2009 / Gene Silencing News - With Thermo Fisher Acquiring Life Tech, RNAi Reagent Space Consolidates Further
April 18, 2013 / Gene Silencing News - RNAi Drugs Field Sees Candidate Failures as More Drugs Enter the Clinic
November 17, 2011 / Gene Silencing News - Maturing RNAi Industry Suggests It Spends Time in Court and in the Lab
August 25, 2011 / Gene Silencing News